Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Mixed-race individuals have hair with varied shapes and more root damage.

The KEBOT system is a highly accurate AI tool for analyzing hair transplants.

Silicone pretreatment protects hair from damage and reduces color fading without interfering with bleaching or dyeing.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

Finasteride, a hair loss medication, may be linked to stroke in young men.

Females are more likely than males to experience long-COVID symptoms and heart issues.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

Dutasteride for hair loss might increase the risk of a rare stroke type.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Body hair can be used to test for alcohol intake, especially in men.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Sapphire blades, double-forceps, and personalized procedures improve hair transplant success and satisfaction.

PRP is more effective than Minoxidil for treating male pattern baldness.

ALUDWIG can help standardize female hair loss assessment from a single image.

Combining PRP with topical minoxidil is most effective for hair growth in androgenetic alopecia.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

PRP therapy for hair loss is safe but its effectiveness is doubtful.

A man developed a unique rash on his neck after taking niacinamide, and doctors recommend considering niacinamide as a cause for similar rashes and using dermatoscopy for diagnosis.

A woman with a rare scalp condition causing a thick scalp and hair loss didn't improve with steroid treatment.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

A dog with a rare skin infection caused by a human fungus was successfully treated with antifungal medication.

Low-level laser therapy may help hair growth, but more research is needed.

Mother and son diagnosed with a rare genetic hair loss condition with no effective treatment.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.